Amicus Therapeutics Files 8-K on Security Holder Vote & Exhibits
Ticker: FOLD · Form: 8-K · Filed: Jun 5, 2025 · CIK: 1178879
| Field | Detail |
|---|---|
| Company | Amicus Therapeutics, Inc. (FOLD) |
| Form Type | 8-K |
| Filed Date | Jun 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing
Related Tickers: AMTX
TL;DR
AMTX filed an 8-K for shareholder vote items and exhibits. No specifics yet.
AI Summary
On June 5, 2025, Amicus Therapeutics, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders and financial statements. The filing does not disclose specific details of the vote or financial results but indicates these items were presented.
Why It Matters
This filing signals that Amicus Therapeutics is engaging in corporate governance activities, including seeking shareholder approval for certain matters and providing updated financial information.
Risk Assessment
Risk Level: low — The filing is procedural and does not contain new material financial or operational information that would immediately impact the company's risk profile.
Key Players & Entities
- Amicus Therapeutics, Inc. (company) — Registrant
- June 5, 2025 (date) — Date of earliest event reported
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the provided text.
What financial statements and exhibits are included in this filing?
The filing states that Financial Statements and Exhibits are included, but the content of these exhibits is not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 5, 2025.
What is the principal executive office address for Amicus Therapeutics, Inc.?
The principal executive office address for Amicus Therapeutics, Inc. is 47 Hulfish Street, Princeton, New Jersey 08542.
What is the Commission File Number for Amicus Therapeutics, Inc.?
The Commission File Number for Amicus Therapeutics, Inc. is 001-33497.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 5, 2025 regarding AMICUS THERAPEUTICS, INC. (FOLD).